MIR Transitions Amid Strategic Acquisition by Quadrivio Silver Economy Fund

Aksìa Group, through its Aksìa Capital V fund, has completed the successful exit of Medical International Research (MIR) by selling it to Quadrivio's Silver Economy Fund and a group of co-investors. This marks the first exit for the Aksìa Capital V fund, achieved in just four years. MIR, a global leader in spirometry, has seen remarkable growth under Aksìa's stewardship, expanding from €11 million to over €22 million in revenues. The strategic acquisition aims to bolster MIR’s position in the medical devices market, particularly in telemedicine and homecare. Both the former and new management have committed to reinvestment in the company, ensuring continuity in its current growth trajectory. The deal utilized numerous advisors for M&A and financial diligence, reflecting a complex but successful transaction process.